Patent application number | Description | Published |
20090297576 | Local Delivery of PAR-1 Antagonists to Treat Vascular Complications - Described herein are methods and medical devices used to deliver bioactive agents locally to patients in need of treatment and/or prevention of cardiovascular conditions Local delivery of protease-activated receptor 1 (PAR-1) antagonists are described herein from implantable medical devices including, but not limited to, stents. | 12-03-2009 |
20120239131 | METHODS AND APPARATUS FOR TREATMENT OF ANEURYSMAL TISSUE - Methods and apparatus for aiding aneurysm repair are provided. Such apparatus is constructed to support or bolster the aneurysmal site and supply a therapeutic agent to aid in healing the surrounding aneurysmal tissue. | 09-20-2012 |
20120315303 | METHODS AND INTRAVASCULAR TREATMENT DEVICES USING PACLITAXEL FOR TREATMENT OF ATHEROSCLEROSIS - Methods and intravascular treatment devices for treating atherosclerosis are provided. | 12-13-2012 |
20130046283 | METHODS AND INTRAVASCULAR TREATMENT DEVICES FOR TREATMENT OF ATHEROSCLEROSIS - Methods and intravascular treatment devices for treating atherosclerosis are provided. | 02-21-2013 |
20130237780 | Biomarker Sampling in the Context of Neuromodulation Devices, Systems, and Methods - Methods for treating a patient using therapeutic renal neuromodulation and associated devices, systems, and methods are disclosed herein. One aspect of the present technology is directed to biomarker sampling in the context of neuromodulation devices, systems, and methods. Some embodiments, for example, are directed to catheters, catheter systems, and methods for sampling biomarkers that change in response to neuromodulation. A system can include, for example, an elongated shaft and a neuromodulation and sampling assembly having a neuromodulation and a sampling element. | 09-12-2013 |
20130282001 | Monitoring of Neuromodulation Using Biomarkers - Provided herein are methods, devices, compositions, and kits for monitoring neuromodulation efficacy based on changes in the level or activity of one or more target biomarkers. | 10-24-2013 |
20150119867 | GASTROINTESTINAL NEUROMODULATION AND ASSOCIATED SYSTEMS AND METHODS - Methods for treating gastrointestinal conditions, conditions associated with sympathetic and/or parasympathetic activity in the gastrointestinal organs, and conditions associated with central sympathetic and/or parasympathetic activity in a patient with therapeutic gastrointestinalneuromodulation and associated systems and methods are disclosed herein. One aspect of the present technology is directed to methods that at least partially inhibit sympathetic neural activity in nerves proximate a gastrointestinal artery of a gastrointestinal organ of a patient. Sympathetic drive in the patient can thereby be reduced in a manner that treats the patient for the gastrointestinal condition. | 04-30-2015 |
20150126978 | METHODS AND DEVICES FOR LOCALIZED INHIBITION OF INFLAMMATION BY ABLATION - Provided herein are methods, systems, and devices for increasing IL-10 expression, inhibiting inflammation, and treating inflammatory conditions using thermal ablation. | 05-07-2015 |